CMPC:BCSEmpresas CMPC S.A. Analysis
Data as of 2026-03-16 - not real-time
$4.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CMPCY is trading flat at $4 with the 20‑day, 50‑day and 200‑day SMAs all converging at the same level, indicating a lack of directional momentum. The RSI is at an extreme 100, flagging an overbought condition, yet the computed trend direction is bearish and volatility over the past 30 days is effectively zero, suggesting the price is stuck without meaningful movement. Volume is reported as stable but effectively zero, and both support and resistance sit at $4, reinforcing a tight price range. The Fear & Greed Index reads 72.88 (Greed), reflecting market optimism despite the stagnant technical picture. With no fundamental data available, no earnings, cash flow, or dividend information, the stock appears highly uncertain and illiquid, making it a risky candidate for new capital. Investors should treat CMPCY as a speculative position with limited upside and consider exiting or avoiding further exposure until clearer financial disclosures emerge.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI at 100 indicating extreme overbought
- Bearish trend despite flat price
- Zero volume and high liquidity risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Lack of fundamental visibility
- Potential for price breakout if new data emerges
- Continued illiquidity
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Uncertain valuation without earnings
- Possible sector or regulatory shifts
- Current price may act as support level
Key Metrics & Analysis
Technical Analysis
TrendBearish
RSI100.0
Support$4.00
Resistance$4.00
MA 20$4.00
MA 50$4.00
MA 200$4.00
MACDNeutral
VolumeStable
Fear & Greed Index72.88
Valuation
GradeOvervalued
TypeValue
Risk Assessment
00
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.